Skip to content

Clinical trials

Phase 2 Carcinoma, Non-Small-Cell Lung trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2 Country / region: Sweden Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20101
20112
20121
20131
20154
20171
20192
20211
20222
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting3
Terminated3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
AstraZeneca2
Bristol-Myers Squibb2
Novartis Pharmaceuticals2
Amgen1
Ass. Prof. Jan Nyman1
Bayer1
ETOP IBCSG Partners Foundation1
GlaxoSmithKline1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung19
Adenocarcinoma of Lung2
Lung Neoplasms2
Melanoma2
Neoplasms2
Biliary Tract Neoplasms1
Breast Neoplasms1
Colorectal Neoplasms1
Neoplasm Metastasis1
Pancreatic Neoplasms1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.